MD, Tufts University School of MedicineGraduate, 1979 - 1983

New England Medical Center, Boston, MA - Residency - 1983 - 1987

Massachusetts General Hospital, Boston, MA - Fellowship - 1987 - 1990

1991: Obstetric & Gynecology

1994: Gynecologic Oncology

Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

1.Granai CO, Frederickson H, Gajewski WH, Goodman A, Goldstein A, and Baden H. The use of Minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies. Eur J Gynecol Oncol 1991; 12 (2) : 129-132. 2.Gustafson ML, Lee MM, Scully RE, Moncure AC, Hirakawa T, Goodman A, Muntz HG, Donahoe PK, MacLaughlin DT, and Fuller AF. A novel tumor marker for ovarian sex Cord tumor with annular tubules. New Eng J Med 1991; 326 (7): 466-471. 3. Rice LW, Lage JM, Berkowitz RS, Goodman A, Muto MG, Knapp RC, Bell DA. Pre- operative serum CA-125 levels in borderline tumors of the ovary. Gynecol Oncol 1992; 46 (2): 226-229. 4. Hutchinson ML, Isenstein LM, Goodman A, Hurley AA, Douglass KL, Mui KK Patten FW, and Zahniser DJ. Homogeneous sampling accounts for the increased diagnostic accuracy using the Thin Prep processor; subsampling: a problem with pap smears. Am J Clin Pathol 1994; 101 (2): 215-219. 5. Goodman A, Bell DA, Rice LW. DNA Ploidy Status: Its Impact on Early Stage Endometrial Adenocarcinoma. Gynecol Oncol 1994; 51: 355-361. 6. Goff BA, Goodman A, Muntz HG, Fuller AF, Nikrui N, and Rice LW. Surgical Stage IV Endometrial Carcinoma: A study of 47 cases. Gynecol Oncol 1994;52: 237-240. 7. Goodman A, Bornstein L, Ball H, Smith DM, and Bankoff M. Chromic phosphate (p-32) therapy in ovarian cancer: problems of intraperitoneal distribution. J Am Col Surg 1994; 179: 401-406. 8. Weitzel J, Patel J, Smith DM, Goodman A, Safaii H, Ball H. Molecular genetic changes associated with ovarian cancer. Gynecol Oncol 1994;; 55: 245-252. 9. Kato DT, Ferry A, Goodman A, Sullinger J, Scully RE, Goff BA, Fuller AF, Rice LW. Uterine papillary serious carcinoma (UPSC) : A clinicopathologic study of 30 cases. Gynecol Oncol 1995; 59:384-389. 10. Goodman A, and Hutchinson ML. Cell surplus on sampling devices after routine cervical cytologic smears; a study of residual cell populations. J Reprod Med 1996; 41:239-241 11. Goodman A, Zukerberg LR, Rice LW, Fuller AF, Young RH, Scully RE. Squamous cell carcinoma of the endometrium: A report of eight cases and a review of the literature. Gynecol Oncol 1996; 61:54-60. 12. Sainz de la Cuesta R, Goodman A, Halverson SS, Fuller AF. En bloc pelvic peritoneal resection of the intraperitoneal pelvic viscera in patients with advanced epithelial ovarian cancer. Cancer Journal 1997; 2:152-157. 13. Schorge JO, Molpus KL, Goodman A, Nikrui N. Fuller AF. The effect of postsurgical therapy on stage III endometrial cancer. Gynecol Oncol 1996; 63: 34-39. 14. Schorge JO, Molpus KL, Koelliker D. Nikrui N, Goodman A, Fuller AF. Stage 1B and IIA cervical cancer with negative lymph nodes: The role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol 1997; 66: 31-35. 15. Duska LR, Flynn C, Chen A, Whall-Strojwas D. Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet Gynecol 1998; 91:278-282. 16. Duska LR, Toth TL, Goodman A. Fertility options for patients with stages Ia2 and Ib cervical cancer: Presentation of two cases and discussion of technical and ethical issues. Obstet Gynecol 1998; 92:656-658. 17. Schorge JO, Goldhaber SZ, Duska LR, Goodman A, Feldman S. Clinically significant venous thromboembolism following gynecologic surgery. J Reprod Med 1999; 44:669-673. 18. Pitras C, Goodman A, Boppart SA, Libus JJ, Fujimoto JG, Brezinski ME. High resolution Imaging of gynecologic neoplasms using optical coherence tomography. Obstet Gynecol 1998; 93 (1): 135-139. 19. Schorge JO, Lee KR, Lee SJ, Flynn CE, Goodman A, Sheets EE. Early cervical Adenocarcinoma: selection criteria for radical surgery. Obstet Gynecol 1999; 94:386-390 20. Feltmate CM, Duska LR, Chang YC, Flynn CE, Nikrui N, Kiggundu E, Goodman A, Fuller AF, McIntyre JF. Predictors of recurrence in surgical stage II endometrial adeno- carcinoma. Gynecol Oncol 1999;73: 407-411. 21. Duska LR, Penson R, Supko JG, Finkelstein DM, Makatsoris T, Gallagher J, Borden K, Goodman A, Fuller AF, Nikrui N, Seiden MV. A phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with G-CSF for relapsed ovarian cancer. Clinical Cancer Research 1999; 5: 1299-1305. 22. Schorge JO, Lee KR, Flynn CE, Goodman A, Sheets EE. Stage Ia1 cervical adeno- carcinoma: definition and treatment. Obstet Gynecol 1999; 93:219-222. 23. Duska LR, Chang Y, Flynn CE, Chen AH, Goodman A, Fuller AF, Nikrui N. Epithelial ovarian carcinoma in the reproductive age group. Cancer 1999; 85: 2623-2629. 24. Houck K, Gallant J, Avis N, Fuller AF, Goodman A. Quality of life in advanced cancer patients: addressing specific concerns. J Palliat Med 1999; 2 (4): 397-402. 25. Weitzel JN, Ding S, Larson GP, Nelson RA, Goodman A, Grendys EC, Ball HG, Krontiris TG. The HRAS1 minisatellite locus and the risk of ovarian cancer. Cancer Research 2000; 60: 259-261. 26. Goodman A, Chaudhuri PM, Tobi-Enos NJ, Hutchinson ML. The false negative rate of cervical smears in high risk HIV seropositive and seronegative women. Int J Gynecol Cancer 2000; 10:27-32. 27. Penson R, Kronish K, Duan Z, Feller A, Stark P, Cook S, Duska L, Fuller A, Goodman A, Nikrui N, MacNeil K, Matulonis U, Preffer F, Seiden MV. Ctytokines IL-1b, IL-2, IL-6, IL-8, MCP-1, GM-CSF, and TNFa in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int J Gynecol Cancer 2000; 10:33-41. 28. Cook S, Penson R, Duska L, Nikrui N, Goodman A, Fuller A, Seiden M. Efficacy and hematologic toxicity of salvage chemotherapy following stem cell- Supported high-dose chemotherapy in women with recruttent ovarian cancer. Gynecol Oncol 2000; 77:48-54. 29. Houck K, Nikrui N, Duska L, Chang Y, Fuller AF, Bell D, Goodman A. Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol 2000; 95: 839-843. 30. Suh-Burgman EJ, Whall-Strojwas D, Chang Y, Hundley D, Goodman A. Risk factors cervical stenosis after loop electrocautery excision procedure. Obstet Gynecol 2000; 96: 657-660. 31. del Carmen MG, McIntyre JF, Fuller AF, Nikrui N, Goodman A. Intraoperative radiation therapy in the treatment of pelvic gynecologic malignancies: A review of fifteen cases. Gynecol Oncol 2000; 79:457-462. 32. Campos SM, Penson RT, Mays AR, Berkowitz RS, Fuller AF, Goodman A, Matulonis UA, Muzikansky A, Seiden MV. The clinical utility of liposomal doxo- Rubicin in recurrent ovarian cancer. Gynecol Oncol 2001; 81: 206-212. 33. Penson RT, Supko JG, Seiden MV, Fuller AF, Berkowtiz RS, Goodman A, Campos SM, MacNeill KM, Cook S, Matulonis UA. A phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent mullerian tumors. Cancer 2001; 92:1156-1167. 34.del Carmen MG, Fuller AF, Matulonis U, Horick NK, Goodman A, Duska LR, Penson R, Campos S, Roche M, Seiden MV. Phase II trial of anastrozole in women with asymptomatic mullerian cancer. Gynecol Oncol 2003; 91:596-602. 35.Dinh TA, Oliva EA, Fuller AF, Lee H, Goodman A. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at Massachusetts General Hospital. Gynecol Oncol 2004; 92:648-652. 36.Penson RT, Oliva E, Skates SJ, Glyptis T, Fuller AF, Goodman A, Seiden MV. Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples. Gynecol Oncol. 2004; 93:98-106. 37.Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, Munkarah AR, Kline R, Burger RA, Goodman A, Burks RT. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A Gynecologic Oncology Group study. J Clin Oncol 2004; 22:2159-2166. 38.Penson RT, Seiden MV, Goodman A, Fuller AFF, Berkowitz RS, Matulonis UA, Krasner C, Lee H, Atkinson T, Campos SM. Phase I trial of escalating doses of toptecan in combnation with a fixed dose of pegylated liposomal doxorubicn in women with mullerian malignancies. Gynecol Oncol 2004; 93:702-707. 39. Duska LR, Berkowitz R , Matulonis U, Muto M , Goodman A, Klein A, Atkinson T,Seiden MV, Campo S. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgrastim (r-metHuG-CSF) support followed by radiotherapy in "high risk" endometrial cancer. Gyn Onc 2005, 96:198-203. 40. Spiryda LB, Fuller AF, Goodman A. Aggressive locally recurrent vulvar cancer: review of cases presented to Massachusetts General Hospital 1990 to present. Int J Gynecol Cancer 2005; 15:884-889. 41. Penson RT, Campos SM, Seiden MV, Krasner C, Fuller AF, Goodman A, Roche M, Willman A, Muzikansky A, Matulonis UA. A Phase II study of fixed dose-rate gemcitabine in patients with relapsed Mullerian tumors. Int J Gynecol Oncol 2005; 15:1035-1041. 42.Matulonis UA, Campos S, Duska L, Krasner CN, Atkinson T, Penson RT, Seiden MV, Verrill C, Fuller AF, Goodman A. Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer. Gynecol Oncol 2006; 103:160-164. 43.Kornblith B, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz, Winer E. Long-term psychological adjustment of older vs. younger survivors of breast and endometrial cancer. Psycho-Oncology 2007 16:895-903. 44. Olawaiye AB, Rauh-Hain JA, Withiam-Leitch M, Rueda B, Goodman A, Del Carmen MG Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma. Gynecol Oncol. 2008; 110;293-298. . 45. Olawaiye AB, Morgan JA, Goodman A, Fuller AF Jr, Penson RT. Epithelioid angiosarcoma of the uterus: a review of management. Arch Gynecol Obstet. 2008 Nov;278(5):401-4. Epub 2008 Jul 19 46. Olawaiye AB, Del Carmen M, Tambouret R, Goodman A, Fuller A, Duska L. Abdominal radical trachelectomy: Success and pitfalls in a general gynecologic oncology practice Gyn Oncol 2009 112:506-510. 47. Mirabeau-Beale KL, Kornblith AB, Penson RT, Lee H, Goodman A, Campos SM, Duska L, Pereira L, Bryan J, Matulonis UA. Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol. 2009 May 27. [Epub ahead of print] Lu W., Matulonis U.,Doherty-Gilman A., Lee H., Dean-Clower E., Rosulek A., Gibson C., Goodman A., Davis R., Buring J., Wayne P., Rosenthal D.S., Penson R. “Acupuncture for chemotherapy induced neutropenia in patients with gynecologic malignancies: A pilot randomized sham controlled trial.” J Alternative Compl Med 15:745-753; 2009.

1.Goodman A, Hill EC. Premalignant & Malignant Disorders of the Uterine Cervix. In: DeCherney AH, Pernoll ML, eds. Current Obstetric and Gynecologic Diagnosis and Treatment; 8th edition, Norwalk, Connecticut: Appleton & Lange, 1994: 921-936. 2.Goodman A. Premalignant & Malignant Disorders of the Uterine Corpus. In: DeCherney AH, Pernoll ML, eds. Current Obstetric and Gynecologic Diagnosis and Treatment; 8th edition, Norwalk, Connecticut: Appleton & Lange, 1994:937-953. 3.Goodman, A. Pelvic Surgery and the Risk of Pulmonary Embolism. Forum (Risk Management Foundation of the Harvard Medical Institutions Inc.) 1994; vol 15 (5):11. 4.Goodman A. Vaginal Cancer. In: Surgical Clinics of North America 7 (2) 347-359; 1998. 5.Fink MJ, Goodman A, Hight E, Mack EM, DeGroot A. Critical Prevention, Critical Care: Gynecological and obstetrical aspects of comprehensive HIV prevention and treatment among incarcerated women. Journal of Correctional Health Care 1998; (2): 201-223. 6.Goodman A. The power to comfort. J Palliat Med 1998; 1 (3): 291. 7.Goodman A. Screening for Cervical Cancer, UpToDate CD ROM, 1999 Updated each year to 2005. 8.Goodman A. Management of the abnormal pap smear, UpToDate CD ROM, 1999 Updated each year to 2005. 9.Goodman A. Evaluation and Management of Genital Tract Bleeding, UpToDate CD ROM, Vol 7, no.1, 1999. Updated each year to 2005. 10.Goodman A. Terminology and differential diagnosis of genital tract bleeding in women, UpToDate CD ROM, vol 7, no. 1, 1999. Updated each year to 2005. 11.Suh-Burgmann E and Goodman A. Surveillance for endometrial cancer in women receiving tamoxifen. Ann Int Med 1999; 131:127-135. 12.Goodman A, Penson RT, Blatman R, McIntyre J, Gioiella ME, Chabner BA, Lynch TJ. A staff dialogue on a socially distanced patient: psychosocial issues faced by patients, their families, and caregivers. Oncologist 1999; 4:417-424. 13.Goodman A. Role of routine human papillomavirus subtyping in cervical screening. Curr Opin Obstet Gynecol 2000; 12:11-14. 14.del Carmen MG and Goodman A. Squamous cell carcinoma in situ of the uterine cervix. Postgrad Obstet Gynecol 2000; 20 (3) : 1-8. 15.del Carmen MG, McIntyre JF, Goodman A. The role of intraoperative radiation therapy (IORT) in the treatment of locally advanced gynecologic malignancies. Oncologist 2000; 5:18-25. 16.Goodman A. Abnormal genital tract bleeding. Clinical Cornerstone 2000 3 (1): 25-35. 17.del Carmen MG and Goodman A. Management of the abnormal papanicolaou smear. Postgrad Obstet Gynecol 2001; 21 (4) : 1-8. 18.Goodman A and Houck K. Anxiety and uncertainty in informed decision making. J Women’s Hlth & gender-based med 2001; 10 (2): 93-94. 19.Goodman A. Management of the Abnormal Papnicolaou smear. UpToDate Cd Rom vol 9 (1) 2001. 20.Goodman A. Book Review of the “The Unexpected Legacy of Divorce: A 25-year Landmark Study” by Wallerstein JS, Lewis J, and Blakeslee S. in The Pharos 2001; 64 (4) : 46-48. 21.Goodman A. Examining the evidence: Human papillomavirus-16 vaccine. OBG Management 2003; 15 (1):14-15. 22.Goodman A. Book review of “Handbook of Gynecologic Oncology” Eds: RR Barakat, MW Bevers, DM Gershenson, WJ Hoskins. In Journal of pelvic surgery 2003. 23.Dorigo O and Goodman A. Premalignant & maligant disorders of the uterine corpus. In Current Obstetric & Gynecologic Diagnosis & Treatment. Ninth edition. Eds DeCherney AH & Nathan L. Lange Medical Books 2003. 24.Goodman A. Screening for human papillomavirus infections of the lower genital tract. Rev Gynaecol Pract 2002; 2:99-101. 25.World Health Organization Classification of Tumours; Pathology and Genetics of Tumours of the Breast and Female Genital Organs ed FA Tavassoli and P Devilee IARC Press Lyon 2003. (role: Contributing author) 26.Goodman A. “Estrogen Replacement therapy after endometrial cancer” Chapter 12 in Uterine Cancer. Eds Fuller AF, Seiden MV, Young RH. BC Decker Inc Hamilton London 2004. 27.Goodman A. “Aftershock” in Tufts Medicine vol 63 (No. 2) p 7-9, Spring 2004. 28.Goodman A. “Critical Mass” Arab Health Magazine Issue six p 34-35, Spring 2004. 29.Goodman A. “Searching for Meaning in Crisis, The earthquake in Bam, Iran.” HaKItsur vol 6(issue 4) Spring 2004/5764. 30.Goodman A.”Surgical cytoreduction in Ovarian cancer: The McCreath/Chi article reviewed”. Oncology 18(5): 656-658; 2004. 31.Russell AH, Seiden MV, Duska LR, Goodman A, Lee SL, Digumarthy SR, Fuller AF. “Cancers of the cervix, vagina, vulva”. Chapter 90 pp 2217-2272; in Clinical Oncology third ed ; ed Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG. Elsevier; Philadelphia 2004. 32.Anhang R, Goodman A, Goldie SJ. HPV Communication: Review of existing research and recommendations for patient education. CA Cancer J Clin 2004; 54:248-259. 33.Goodman A. Endometrial cancer with concurrent ovarian malignancy: assessing the risks. Obstet Gynecol 2005; 106 (4) 680-681. 34.Goodman A. Religious and cultural interpretation of illness in the Boston Haitian community and its impact on healthcare. Gynecol Oncol 2005; 99: S199-S200. 35.Goodman A, Holschneider CH. Management of Abnormal cervical cytology. UpToDate version 14.1, 2006. 36.Feldman S, Goodman A. Tests for screening for cervical cancer. UpToDate version 14.1, 2006. 37.Feldman S, Goodman A. Procedures for obtaining cells for cervical cytology. UpToDate version 14.1, 2006. 38.Feldman S, Goodman A. Screening for cervical cancer: Clinical recommendations. UpToDate version 14.1, 2006. 39.Goodman A. Evaluation & management of abnormal uterine bleeding in premenopausal women. UpToDate version 14.1, 2006. 40.Goodman A. Evaluation & management of abnormal uterine bleeding in postmenopausal women. UpToDate version 14.1, 2006. 41.Goodman A. Terminology & differential diagnosis of genital tract bleeding in women. UpToDate version 14.1, 2006. 42.Goodman A “Screening for cervical cancer: the current approach. Family Practice Recertification January 2007 29 (1):43-51. 43.Goodman A. “Overview of causes of genital tract bleeding in women”. UpToDate version 15.2, 2007. 44.Goodman A. “Terminology and evaluation of abnormal uterine bleeding in premenopausal women” UpToDate version 15.2, 2007. 45.Goodman A. “Initial approach to the premenopausal woman with abnormal uterine bleeding” UpToDate version 15.2, 2007. 46.Goodman A. “The evaluation and management of uterine bleeding in postmenopausal women”. UpToDate version 15.2, 2007. 47.Goodman A, Holschneider CH. “The cervical cytology report’ UpToDate version 15.2, 2007. 48.Feldman S, Goodman A. “Tests for screening for cervical cancer: Cervical cytology, human papillomavirus testing, and visual inspection.” UpToDate version 15.2, 2007. 49.Goodman A, Holschneider CH. “Management of atypical squamous cells (ASC-US and ASC-H) on cervical cytology”. UpToDate version 15.2, 2007. 50.Goodman A, Holschneider CH. “Management of low and high grade squamous intraepithelial lesions on cervical cytology.” UpToDate version 15.2, 2007. 51.Feldman S, Goodman A. “Screening for cervical cancer: Clinical recommendations”. UpToDate version 15.2, 2007. 52.Goodman A , Goff B. Screening for endometrial cancer in “Uterine Cancer, Screening, Diagnosis, Treatment.” eds Franco Muggia and Ester Oliva Spriinger.com/humana 2009. 53.Feldman S, Goodman A. “Tests for screening for cervical cancer: cervical cytology, human papillomavirus testing, and visual inspection” UpToDate version 17.1 : 2009. 54.Goodman A, Holschneider C. “Management of atypical and malignant glandular cells on cervical cytology” UpToDate version 17.1 : 2009. 55.Goodman A, Holschneider C. “Cervical Cytology Report” UpToDate version 17.1 : 2009. 56. Sirovich BE, Feldman S, Goodman A. “Screening for cervical cancer” UpToDate version 17.1 : 2009. 57. Goodman A, Holschneider C. “Cervical Cytology: Management of high grade squamous intraepithelial lesions.” UpToDate version 17.1 : 2009. 58. Goodman A, Holschneider C. “Cervical Cytology: Management of low grade squamous intraepithelial lesions.” UpToDate version 17.1 : 2009. 59. Feldman S, Goodman A. “Cervical Cytology: Techniques for Obtaining Cells” UpToDate version 17.1 : 2009. 60.Goodman A. “Evaluation and Management of Uterine Bleeding in Postmenopausal women” UpToDate version 17.1 : 2009. 61. Goodman A. “Terminology and Evaluation of abnormal Uterine Bleeding in Premenopausal women” UpToDate version 17.1 : 2009. 62. Goodman A. “Overview of causes of genital tract bleeding in women” UpToDate version 17.1 : 2009. 63. Goodman A. “In itial Approach to the Premenopausal woman with abnormal Uterine Bleeding” UpToDate version 17.1 : 2009.

1.Goodman A, Sullinger J. Rice LW, and Fuller AF. Clear cell adenocarcinoma of the vagina: A second primary in a diethylstilbestrol exposed woman? Gynecol Oncol 1991; 43:173-177. 2.Goodman A, Zukerberg L, Nikrui N, and Scully RE. Development of nondiethylstil- bestrol associated vaginal adenosis and clear cell carcinoma following treatment for condyloma accuminata. Cancer 1991; 68: 1628-1632. 3.Multani P, Supko J, Batchelor T, Goodman A, Seiden M. Case report: Effective treatment of leptomeningeal metastases from ovarian cancer with topotecan. Cancer Therapeutics. 1998; 1:33-36. 4.Mirashemi R, Kratz A, Weir MM, Molpus Kl, Goodman A. Vaginal small cell carcinoma mimicking a Bartholin’s gland abscess: a case report. Gynecol Oncol 1998; 68: 297-300. 5.Duska LR, Flynn C. Goodman A. Masculinizing sclerosing stromal cell tumor in pregnancy: report of a case and review of the literature. Eur J Gynaec Oncol 1998; 19 (5) : 441-443. 6.Goodman A, Cagliero E. Megestrol-induced clinical adrenal insufficiency. Eur J Gynaec Oncol 2000; 21:117-11. 7.El Khoury J, Stickkelbroeck MML, Goodman A, Rubin RH, Cosimi AB, Fishman JA. Postmenopausal tubo-ovarian abscess due to Pseudomonas Aeruginosa in a renal transplant patient. A case report and review of the literature. Transplantation 2001; 72(7):1241-1243. 8.del Carmen M, Lovett D, Goodman A. A case of Mullerian adenosarcoma of the uterus treated with lipoomal doxorubicin. Gynecol Oncol 2003; 88:456-458. 9..Goodman A, Wilbur DC. Case 32-2003: A 37 year old woman with atypical squamous cells on a Papincolau smear. N Eng J Med 2003; 349:1555-1564. 10.Olawaiye A, Withiam-Leitch M, Prabhakar H, Goodman A. An unusual presentation of endometrial cancer: a case report and literature review. Archives of Gynecology and Obstetrics. Arch Gynecol Obstet. 2008 Aug;278(2):103-6. Epub 2008 Mar 12. 11.Ko E, Lee S, Goodman. Gemcitabine Pulmonary Toxicity in Ovarian Cancer. The Oncologist Volume 13, Number 7 pp. 807-811. 2008. 12. Goldstein MA, Goodman A, del Carmen MG, Wilbur DC. Case records of the Massachusetts General Hospital. Case 10-2009. A 23-year-old woman with an abnormal Papanicolaou smear. N Engl J Med. 2009 Mar 26;360(13):1337-44.

Fischer M, Goodman A. Colposcopy: Answers to your questions Goodman A. Human Papillomavirus. In: Training Manual STD/HIV Prevention Training Center of New England; Mass. Dept. Public Health. 1997. Self-Study Module One: Approach to Sexual History Taking and STD Screening. STD/HIV prevention training center of New England. 2000 (authors: Ratelle S, Daly P, Dumas B; Core curriculum committee: Lambl B, Felsenstein D, Thomas WE, Zaccaria E, Carregal C, Goodman A) Celi A, Kim A, Goodman A “The abnormal Pap smear” in The MGH ambulatory care syllabus, 2000. “The abnormal Pap smear” The MGH Primary Care Syllabus, 2001. “Abnormal Vaginal Bleeding” The MGH Primary Care Syllabus, 2001. “Abnormal Pap Smear” in “The MGH Primer of Outpatient Medicine” Lippincott Williams & Wilkins 2002. “Abnormal Vaginal Bleeding” in “The MGH Primer of Outpatient Medicine” Lippincott Williams & Wilkins 2002.